Shareholdings
| Concept |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
|---|---|---|---|---|
| Shareholdings | ||||
| Reporting company | ||||
| Details of specified investment shares held for purposes other than pure investment | ||||
| Issue |
株式会社ファンペップ
|
Fresh TracksTherapeutics, Inc.
|
— | — |
| Number of shares |
200,000
xbrli:shares
|
6,535
xbrli:shares
|
200,000
xbrli:shares
|
6,535
xbrli:shares
|
| Carrying amount |
27,000,000
JPY
|
0
JPY
|
27,000,000
JPY
|
0
JPY
|
| Purpose of shareholding, overview of business alliance, quantitative effects of shareholding and reason for increase in number of shares |
DNAワクチンの共同開発および関係強化のため。
|
HGF遺伝子治療用製品に関する共同開発および関係強化のため。
|
— | — |
| Whether issuer of aforementioned shares holds reporting company's shares |
無
|
無
|
— | — |